Joanne Wuensch
Stock Analyst at Citigroup
(4.30)
# 422
Out of 4,996 analysts
407
Total ratings
63.24%
Success rate
11.51%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Downgrades: Neutral | $97 → $72 | $67.55 | +6.59% | 21 | Aug 28, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $10 → $11 | $12.00 | -8.33% | 19 | Aug 21, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.6 → $4.5 | $3.48 | +29.31% | 12 | Aug 21, 2025 | |
| MDT Medtronic | Maintains: Buy | $99 → $101 | $94.22 | +7.20% | 21 | Aug 21, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $185 → $200 | $179.71 | +11.29% | 13 | Aug 21, 2025 | |
| IRTC iRhythm Technologies | Maintains: Buy | $167 → $183 | $170.81 | +7.14% | 20 | Aug 21, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $89 → $93 | $72.46 | +28.35% | 6 | Jul 31, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $157 → $155 | $133.55 | +16.06% | 22 | Jul 18, 2025 | |
| PEN Penumbra | Maintains: Neutral | $320 → $285 | $253.37 | +12.48% | 25 | Jul 9, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Neutral | $38 → $47 | $39.11 | +20.17% | 7 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $34 → $32 | $21.98 | +45.59% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $14.50 | +3.45% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $71 → $90 | $48.17 | +86.84% | 8 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $443 → $455 | $369.02 | +23.30% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.74 | +138.51% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $590 → $650 | $441.12 | +47.35% | 17 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $318.00 | +19.50% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $95 | $76.25 | +24.59% | 20 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $82 → $102 | $67.10 | +52.01% | 14 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $98.18 | +27.32% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $133 → $140 | $101.50 | +37.93% | 6 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $132 → $162 | $79.92 | +102.70% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $16 → $22 | $13.20 | +66.67% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $134 → $120 | $98.24 | +22.15% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $184.60 | +35.43% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $73.92 | -6.66% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $270.27 | -53.01% | 6 | Dec 10, 2018 |
The Cooper Companies
Aug 28, 2025
Downgrades: Neutral
Price Target: $97 → $72
Current: $67.55
Upside: +6.59%
Tandem Diabetes Care
Aug 21, 2025
Maintains: Neutral
Price Target: $10 → $11
Current: $12.00
Upside: -8.33%
Sight Sciences
Aug 21, 2025
Maintains: Neutral
Price Target: $3.6 → $4.5
Current: $3.48
Upside: +29.31%
Medtronic
Aug 21, 2025
Maintains: Buy
Price Target: $99 → $101
Current: $94.22
Upside: +7.20%
Johnson & Johnson
Aug 21, 2025
Maintains: Buy
Price Target: $185 → $200
Current: $179.71
Upside: +11.29%
iRhythm Technologies
Aug 21, 2025
Maintains: Buy
Price Target: $167 → $183
Current: $170.81
Upside: +7.14%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Buy
Price Target: $89 → $93
Current: $72.46
Upside: +28.35%
Abbott Laboratories
Jul 18, 2025
Maintains: Buy
Price Target: $157 → $155
Current: $133.55
Upside: +16.06%
Penumbra
Jul 9, 2025
Maintains: Neutral
Price Target: $320 → $285
Current: $253.37
Upside: +12.48%
Establishment Labs Holdings
Jul 9, 2025
Maintains: Neutral
Price Target: $38 → $47
Current: $39.11
Upside: +20.17%
Jul 9, 2025
Maintains: Neutral
Price Target: $34 → $32
Current: $21.98
Upside: +45.59%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $14.50
Upside: +3.45%
Jul 9, 2025
Upgrades: Buy
Price Target: $71 → $90
Current: $48.17
Upside: +86.84%
May 22, 2025
Maintains: Buy
Price Target: $443 → $455
Current: $369.02
Upside: +23.30%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.74
Upside: +138.51%
May 22, 2025
Maintains: Buy
Price Target: $590 → $650
Current: $441.12
Upside: +47.35%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $318.00
Upside: +19.50%
May 22, 2025
Maintains: Buy
Price Target: $84 → $95
Current: $76.25
Upside: +24.59%
May 22, 2025
Maintains: Buy
Price Target: $82 → $102
Current: $67.10
Upside: +52.01%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $98.18
Upside: +27.32%
May 22, 2025
Upgrades: Buy
Price Target: $133 → $140
Current: $101.50
Upside: +37.93%
Dec 11, 2024
Upgrades: Buy
Price Target: $132 → $162
Current: $79.92
Upside: +102.70%
Nov 5, 2024
Maintains: Sell
Price Target: $16 → $22
Current: $13.20
Upside: +66.67%
Jul 10, 2024
Maintains: Neutral
Price Target: $134 → $120
Current: $98.24
Upside: +22.15%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $184.60
Upside: +35.43%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $73.92
Upside: -6.66%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $270.27
Upside: -53.01%